Skip to main content

David Tyronne Howton

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About David Tyronne Howton

David Tyronne Howton is recorded as COO at Solid Biosciences Inc. (SLDB). David Tyronne Howton was last confirmed as General Counsel at Sarepta Therapeutics, Inc. (SRPT) in a filing dated April 20, 2021. Earlier roles on record: General Counsel at Sarepta Therapeutics, Inc. (SRPT) until December 14, 2020. The proxy statement of Solid Biosciences Inc. reports total compensation of $2,588,827 for David Tyronne Howton in fiscal 2025, including a base salary of $513,422. Disclosed compensation is on record for 8 fiscal years.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Solid Biosciences Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Solid Biosciences Inc. (SLDB) $513,422 $2,588,827
2024 Solid Biosciences Inc. (SLDB) $473,200 $2,563,014
2023 Solid Biosciences Inc. (SLDB) $455,000 $648,880
2022 Solid Biosciences Inc. (SLDB) $35,030 $1,017,870
2020 Sarepta Therapeutics, Inc. (SRPT) $470,695 $5,703,078
2019 Sarepta Therapeutics, Inc. (SRPT) $458,844 $4,196,622
2018 Sarepta Therapeutics, Inc. (SRPT) $438,185 $3,129,375
2017 Sarepta Therapeutics, Inc. (SRPT) $407,176 $1,823,528

Recent activity

No call appearances or filed executive changes recorded yet.